These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26075254)

  • 1. Deguelin induces apoptosis by targeting both EGFR-Akt and IGF1R-Akt pathways in head and neck squamous cell cancer cell lines.
    Baba Y; Fujii M; Maeda T; Suzuki A; Yuzawa S; Kato Y
    Biomed Res Int; 2015; 2015():657179. PubMed ID: 26075254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma.
    Baba Y; Maeda T; Suzuki A; Takada S; Fujii M; Kato Y
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the insulin-like growth factor-1 receptor induces resistance to epidermal growth factor receptor antagonism in head and neck squamous carcinoma cells.
    Jameson MJ; Beckler AD; Taniguchi LE; Allak A; Vanwagner LB; Lee NG; Thomsen WC; Hubbard MA; Thomas CY
    Mol Cancer Ther; 2011 Nov; 10(11):2124-34. PubMed ID: 21878657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deguelin induces both apoptosis and autophagy in cultured head and neck squamous cell carcinoma cells.
    Yang YL; Ji C; Bi ZG; Lu CC; Wang R; Gu B; Cheng L
    PLoS One; 2013; 8(1):e54736. PubMed ID: 23372762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells.
    Chun KH; Kosmeder JW; Sun S; Pezzuto JM; Lotan R; Hong WK; Lee HY
    J Natl Cancer Inst; 2003 Feb; 95(4):291-302. PubMed ID: 12591985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-I receptor signaling pathway induces resistance to the apoptotic activities of SCH66336 (lonafarnib) through Akt/mammalian target of rapamycin-mediated increases in survivin expression.
    Oh SH; Jin Q; Kim ES; Khuri FR; Lee HY
    Clin Cancer Res; 2008 Mar; 14(5):1581-9. PubMed ID: 18316583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of deguelin on proliferation and apoptosis of MCF-7 breast cancer cells by phosphatidylinositol 3-kinase/Akt signaling pathway].
    Chu ZH; Liang XH; Zhou XL; Huang RF; Zhan Qz; Jiang JW
    Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):533-8. PubMed ID: 21565140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticancer efficacy of deguelin in human prostate cancer cells targeting glycogen synthase kinase-3 β/β-catenin pathway.
    Thamilselvan V; Menon M; Thamilselvan S
    Int J Cancer; 2011 Dec; 129(12):2916-27. PubMed ID: 21472727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Icariside II induces apoptosis via inhibition of the EGFR pathways in A431 human epidermoid carcinoma cells.
    Wu J; Zuo F; Du J; Wong PF; Qin H; Xu J
    Mol Med Rep; 2013 Aug; 8(2):597-602. PubMed ID: 23807305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of receptor function in colon carcinoma cells determined by cross-talk between type I insulin-like growth factor receptor and epidermal growth factor receptor.
    Hu YP; Patil SB; Panasiewicz M; Li W; Hauser J; Humphrey LE; Brattain MG
    Cancer Res; 2008 Oct; 68(19):8004-13. PubMed ID: 18829558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of deguelin-induced apoptosis in transformed human bronchial epithelial cells.
    Lee HY
    Biochem Pharmacol; 2004 Sep; 68(6):1119-24. PubMed ID: 15313408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapy.
    Secades P; de Santa-María IS; Merlo A; Suarez C; Chiara MD
    Head Neck; 2015 Aug; 37(8):1150-62. PubMed ID: 24798801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of AMP-activated protein kinase and Akt-regulated survivin in lung cancer chemopreventive activities of deguelin.
    Jin Q; Feng L; Behrens C; Bekele BN; Wistuba II; Hong WK; Lee HY
    Cancer Res; 2007 Dec; 67(24):11630-9. PubMed ID: 18089792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deguelin, an Akt inhibitor, down-regulates NF-κB signaling and induces apoptosis in colon cancer cells and inhibits tumor growth in mice.
    Kang HW; Kim JM; Cha MY; Jung HC; Song IS; Kim JS
    Dig Dis Sci; 2012 Nov; 57(11):2873-82. PubMed ID: 22623043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel antitumor activity of deguelin targeting the insulin-like growth factor (IGF) receptor pathway via up-regulation of IGF-binding protein-3 expression in breast cancer.
    Suh YA; Kim JH; Sung MA; Boo HJ; Yun HJ; Lee SH; Lee HJ; Min HY; Suh YG; Kim KW; Lee HY
    Cancer Lett; 2013 May; 332(1):102-9. PubMed ID: 23348700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic apoptosis in head and neck squamous cell carcinoma cells by co-inhibition of insulin-like growth factor-1 receptor signaling and compensatory signaling pathways.
    Axelrod MJ; Mendez RE; Khalil A; Leimgruber SS; Sharlow ER; Capaldo B; Conaway M; Gioeli DG; Weber MJ; Jameson MJ
    Head Neck; 2015 Dec; 37(12):1722-32. PubMed ID: 24986420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling.
    Andersson MK; Afshari MK; Andrén Y; Wick MJ; Stenman G
    J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deguelin exerts anticancer activity of human gastric cancer MGC-803 and MKN-45 cells in vitro.
    Kang W; Zheng X; Wang P; Guo S
    Int J Mol Med; 2018 Jun; 41(6):3157-3166. PubMed ID: 29512685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
    Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C
    Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deguelin action involves c-Met and EGFR signaling pathways in triple negative breast cancer cells.
    Mehta R; Katta H; Alimirah F; Patel R; Murillo G; Peng X; Muzzio M; Mehta RG
    PLoS One; 2013; 8(6):e65113. PubMed ID: 23762292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.